Clinical Trials Directory

Trials / Completed

CompletedNCT00977730

The Effect of Protandim on Non-alcoholic Steatohepatitis

The Effect of the Dietary Supplement Protandim on Non-Alcoholic Steatohepatitis: A Randomized, Double Blind, Placebo-Controlled Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
70 (actual)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the effect of Protandim on the degree of liver injury after one year of supplementation. Protandim is a nutritional supplement composed of the following 5 botanical extracts: Bacopa Moniera extract, Milk Thistle extract, Ashwagandha powder, Green tea, and Turmeric extract. Protandim is commercially available and can be purchased without a prescription. Our findings could lead to a better understanding of the role of oxidative stress and antioxidant therapy in NASH and may ultimately help improve patient care. Hypothesis #1: Protandim will lead to a significant improvement in NAS compared to placebo. Hypothesis #2: Protandim will lead to a significant decrease in serum markers of oxidative stress and liver chemistry tests. Hypothesis #3: Protandim will lead to decreased levels of TNF- α compared to placebo.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProtandim1 675 mg capsule Protandim PO/day vs. 1 sugar pill PO/day
DIETARY_SUPPLEMENTPlacebo1 675 mg capsule Protandim PO/day vs. 1 sugar pill PO/day

Timeline

Start date
2008-07-01
Primary completion
2011-07-01
Completion
2011-07-01
First posted
2009-09-16
Last updated
2013-02-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00977730. Inclusion in this directory is not an endorsement.